Skip to main content
Zai Lab Ltd logo

Zai Lab Ltd — Investor Relations & Filings

Ticker · ZLAB ISIN · US98887Q1040 US Manufacturing
Filings indexed 639 across all filing types
Latest filing 2025-12-12 Director's Dealing
Country US United States of America
Listing US ZLAB

About Zai Lab Ltd

https://www.zailaboratory.com/

Zai Lab Ltd. is a global, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines. The company focuses on advancing breakthrough therapies to address significant unmet medical needs for patients worldwide. Its strategy combines in-house discovery with strategic global partnerships to build a robust product pipeline. The primary therapeutic areas of focus include oncology, immunology, neuroscience, and infectious diseases. Zai Lab aims to leverage its competencies to positively impact human health by bringing novel treatments from the laboratory to patients.

Recent filings

Filing Released Lang Actions
Director's Dealing 2025
Director's Dealing
2025-12-12 English
Director's Dealing 2025
Director's Dealing
2025-11-25 English
Regulatory Filings 2025
Regulatory Filings
2025-11-21 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-12 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.